Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: Oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification

Urology

Volumn 78, Issue 3, 2011, Pages 607-613

  Ploussard, Guillaume ^a,b   Masson Lecomte, Alexandra ^c   Beauval, Jean Baptiste ^d   Ouzzane, Adil ^e   Bonniol, Romain ^f   Buge, Franois ^g   Fadli, Saad ^h   Rouprect, Morgan ^c   Rebillard, Xavier ^h   Gaschignard, Nicolas ^g   Pfister, Christian ^f   Villers, Arnauld ^e   Soulié, Michel ^d   Salomon, Laurent ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g CH la Roche sur Yon ^*  (France)

^h Clinique Beau Soleil   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CORRELATIONAL STUDY; DISEASE SEVERITY; FOLLOW UP; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL RISK; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052362815     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.05.021     Document Type: Article

References (24)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics CA Cancer J Clin 58 2008 71 96
2. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974 (Pubitemid 28445094)
3. O. Yossepowitch, S.E. Eggener, and F.J. Bianco Jr Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods J Urol 178 2007 493 499 (Pubitemid 47030486)
4. O. Yossepowitch, S.E. Eggener, and A.M. Serio Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy Eur Urol 53 2008 950 959 (Pubitemid 351434496)
5. S. Loeb, E.M. Schaeffer, and B.J. Trock What are the outcomes of radical prostatectomy for high-risk prostate cancer? Urology 76 2010 710 714
6. G.D. Grossfeld, D.M. Latini, and D.P. Lubeck Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer J Urol 169 2003 157 163 (Pubitemid 35461577)
7. M. Lodde, F. Harel, and L. Lacombe Substratification of high-risk localised prostate cancer treated by radical prostatectomy World J Urol 26 2008 225 229
8. C.T. Nguyen, A.M. Reuther, and A.J. Stephenson The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival J Urol 181 2009 75 80
9. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80 (Pubitemid 350166735)
10. M.V. Meng, E.P. Elkin, and D.M. Latini Treatment of patients with high risk localized prostate cancer: results from Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) J Urol 173 2005 1557 1561 (Pubitemid 40528444)
11. M.W. Kattan, T.M. Wheeler, and P.T. Scardino Postoperative nomogram for disease recurrence after prostatectomy for prostate cancer J Clin Oncol 17 1999 1499 1507 (Pubitemid 29220858)
12. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term folloup of a randomized clinical trial J Urol 181 2009 956 962
13. E.M. Messing, J. Manola, and M. Sarosdy Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer N Engl J Med 341 1999 1781 1788
14. E.M. Messing, J. Manola, and J. Yao Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy Lancet Oncol 7 2006 472 479 (Pubitemid 43779173)
15. M.W. Kattan, J.A. Eastham, and A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771 (Pubitemid 28259189)
16. M.R. Cooperberg, S.J. Freedland, and D.J. Pasta Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy Cancer 107 2006 2384 2391 (Pubitemid 44748521)
17. S.A. Boorjian, R.J. Karnes, and L.J. Rangel Mayo Clinic validation of the D'Amico risk group classification for predicting survival following radical prostatectomy J Urol 179 2008 1354 1360
18. P.J. Bastian, M.L. Gonzalgo, and W.J. Aronson Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10 Cancer 107 2006 1265 1272 (Pubitemid 44452775)
19. G. Ploussard, L. Salomon, and Y. Allory Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer BJU Int 106 2010 86 90
20. P.A. Kupelian, J.C. Buchsbaum, and M. Elshaikh Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above Cancer 95 2002 2302 2307 (Pubitemid 35351135)
21. T.D. Denberg, L.M. Glodé, and J.F. Steiner Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma BJU Int 98 2006 335 340
22. C.L. Amling, M.L. Blute, and E.J. Bergstralh Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years J Urol 164 2000 101 105 (Pubitemid 30434268)
23. C.G. Eden, A. Arora, and P. Rouse Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer BJU Int 106 2010 537 542
24. M.E. Hyndman, J.K. Mullins, and C.P. Pavlovich Pelvic node dissection in prostate cancer: extended, limited, or not at all? Curr Opin Urol 20 2010 211 217